|
1
|
Mansoor S, Yerian L, Kohli R, Xanthakos S,
Angulo P, Ling S, Lopez R, Christine CK, Feldstein AE and Alkhouri
N: The evaluation of hepatic fibrosis scores in children with
nonalcoholic fatty liver disease. Dig Dis Sci. 60:1440–1447. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roy S, Benz F, Luedde T and Roderburg C:
The role of miRNAs in the regulation of inflammatory processes
during hepatofibrogenesis. Hepatobiliary Surg Nutr. 4:24–33.
2015.PubMed/NCBI
|
|
3
|
Hegab Z, Gibbons S, Neyses L and Mamas MA:
Role of advanced glycation end products in cardiovascular disease.
World J Cardiol. 4:90–102. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barlovic DP, Soro-Paavonen A and
Jandeleit-Dahm KA: RAGE biology, atherosclerosis and diabetes. Clin
Sci (Lond). 121:43–55. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lee UE and Friedman SL: Mechanisms of
hepatic fibrogenesis. Best Pract Res Clin Gastroenterol.
25:195–206. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lohwasser C, Neureiter D, Popov Y, Bauer M
and Schuppan D: Role of the receptor for advanced glycation end
products in hepatic fibrosis. World J Gastroenterol. 15:5789–5798.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guimarães EL, Empsen C, Geerts A and van
Grunsven LA: Advanced glycation end products induce production of
reactive oxygen species via the activation of NADPH oxidase in
murine hepatic stellate cells. J Hepatol. 52:389–397. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xia JR, Liu NF and Zhu NX: Specific siRNA
targeting the receptor for advanced glycation end products inhibits
experimental hepatic fibrosis in rats. Int J Mol Sci. 9:638–661.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lin J, Tang Y, Kang Q, Feng Y and Chen A:
Curcumin inhibits gene expression of receptor for advanced
glycation end-products (RAGE) in hepatic stellate cells in vitro by
elevating PPARγ activity and attenuating oxidative stress. Br J
Pharmacol. 166:2212–2227. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Goodwin M, Herath C, Jia Z, Leung C,
Coughlan MT, Forbes J and Angus P: Advanced glycation end products
augment experimental hepatic fibrosis. J Gastroenterol Hepatol.
28:369–376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hsu WH, Lee BH, Hsu YW and Pan TM:
Peroxisome proliferator-activated receptor-γ activators monascin
and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in
hepatic stellate cells through regulating the oxidative stress
pathway but independent of the receptor for advanced glycation end
products signaling. J Agric Food Chem. 61:6873–6879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scheuer PJ: Classification of chronic
viral hepatitis: A need for reassessment. J Hepatol. 13:372–374.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hyogo H and Yamagishi S: Advanced
glycation end products (AGEs) and their involvement in liver
disease. Curr Pharm Des. 14:969–972. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pusterla T, Nèmeth J, Stein I, Wiechert L,
Knigin D, Marhenke S, Longerich T, Kumar V, Arnold B, Vogel A, et
al: Receptor for advanced glycation endproducts (RAGE) is a key
regulator of oval cell activation and inflammation-associated liver
carcinogenesis in mice. Hepatology. 58:363–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Watson AM, Gray SP, Jiaze L, Soro-Paavonen
A, Wong B, Cooper ME, Bierhaus A, Pickering R, Tikellis C, Tsorotes
D, et al: Alagebrium reduces glomerular fibrogenesis and
inflammation beyond preventing RAGE activation in diabetic
apolipoprotein E knockout mice. Diabetes. 61:2105–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fehrenbach H, Weiskirchen R, Kasper M and
Gressner AM: Up-regulated expression of the receptor for advanced
glycation end products in cultured rat hepatic stellate cells
during transdifferentiation to myofibroblasts. Hepatology.
34:943–952. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang SC, Zheng YH, Yu PP, Min TH, Yu FX,
Ye C, Xie YK and Zhang QY: Lentiviral vector-mediated
down-regulation of IL-17A receptor in hepatic stellate cells
results in decreased secretion of IL-6. World J Gastroenterol.
18:3696–3704. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lee BH, Hsu WH, Hsu YW and Pan TM:
Suppression of dimerumic acid on hepatic fibrosis caused from
carboxymethyl-lysine (CML) by attenuating oxidative stress depends
on Nrf2 activation in hepatic stellate cells (HSCs). Food Chem
Toxicol. 62:413–419. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tang Y and Chen A: Curcumin eliminates the
effect of advanced glycation end-products (AGEs) on the divergent
regulation of gene expression of receptors of AGEs by interrupting
leptin signaling. Lab Invest. 94:503–516. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Klironomos S, Notas G, Sfakianaki O,
Kiagiadaki F, Xidakis C and Kouroumalis E: Octreotide modulates the
effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat
hepatic stellate cells. Regul Pept. 188:5–12. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ming-Ju H, Yih-Shou H, Tzy-Yen C and
Hui-Ling C: Hepatitis C virus E2 protein induce reactive oxygen
species (ROS)-related fibrogenesis in the HSC-T6 hepatic stellate
cell line. J Cell Biochem. 112:233–243. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Radwan MI, Pasha HF, Mohamed RH, Hussien
HI and El-Khshab MN: Influence of transforming growth factor-β1 and
tumor necrosis factor-α genes polymorphisms on the development of
cirrhosis and hepatocellular carcinoma in chronic hepatitis C
patients. Cytokine. 60:271–276. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang YY, Liu RS, Lee PC, et al: Anti-VEGFR
agents ameliorate hepatic venous dysregulation/microcirculatory
dysfunction, splanchnic venous pooling and ascites of
NASH-cirrhotic rat. Liver Int. 34:521–534. 2014. View Article : Google Scholar : PubMed/NCBI
|
